Deadenylation-independent stage-specific mRNA degradation in Leishmania by Haile, Simon et al.
1634–1644 Nucleic Acids Research, 2008, Vol. 36, No. 5 Published online 3 February 2008
doi:10.1093/nar/gkn019
Deadenylation-independent stage-specific mRNA
degradation in Leishmania
Simon Haile, Aure ´lien Dupe ´ and Barbara Papadopoulou*
Research Centre in Infectious Diseases, CHUL Research Centre and Department of Medical Biology, Faculty of
Medicine, Laval University, Quebec, Canada
Received December 4, 2007; Revised and Accepted January 10, 2008
ABSTRACT
The life cycle of Leishmania alternates between
developmental forms residing within the insect
vector (e.g. promastigotes) and the mammalian
host (amastigotes). In Leishmania nearly all control
of gene expression is post-transcriptional and
involves sequences in the 3’-untranslated regions
(3’UTRs) of mRNAs. Very little is known as to how
these cis-elements regulate RNA turnover and
translation rates in trypanosomatids and nothing is
known about mRNA degradation mechanisms in
Leishmania in particular. Here, we use the amastin
mRNA—an amastigote-specific transcript—as a
model and show that a »100nt U-rich element
(URE) within its 3’UTR significantly accounts for
developmental regulation. RNase-H-RNA blot ana-
lysis revealed that a major part of the rapid
promastigote-specific degradation of the amastin
mRNA is not initiated by deadenylation. This is in
contrast to the amastin mRNA in amastigotes and to
reporter RNAs lacking the URE, which, in common
with most eukaryotic mRNAs studied to-date, are
deadenylated before being degraded. Moreover, our
analysis did not reveal a role for decapping in the
stage-specific degradation of the amastin mRNA.
Overall, these results suggest that degradation of
the amastin mRNA of Leishmania is likely to be
bi-phasic, the first phase being stage-specific and
dependent on an unusual URE-mediated pathway of
mRNA degradation.
INTRODUCTION
Parasitic species belonging to the kinetoplastid group
of protozoans are of high medical and veterinary
importance mainly in tropical and subtropical countries.
These include trypansomatids such as Leishmania spp.
(Leishmaniasis), Trypanosoma brucei (Sleeping sickness)
and Trypanosoma cruzi (Chagas disease). Their life cycle
involves a mammalian host and an arthropod vector.
The parasites face disparate conditions during their life
cycle, a drastic change in temperature between their insect
( 20–258C) and mammalian (378C) hosts being typically a
shared challenge. Other changes can be unique to the life
style of a given parasite (e.g. the acidic pH that Leishmania
spp. face within the phagolysosomes of host macro-
phages). The parasites employ various adaptive strategies
to be able to survive and grow in their distinct niches.
These stage- or species-speciﬁc structural and metabolic
adaptations are associated with signiﬁcant changes in gene
expression as evidenced by recent functional genomic
analyses [Rochette et al., unpublished data; (1–4)].
Kinetoplastids branched very early from the eukaryotic
lineage and perhaps because of these they display several
unusual or unique biological features. Tens to hundreds of
genes are collinearly transcribed into a polycistronic
mRNAs (5–7). Individual mRNAs are resolved from
nuclear pre-mRNAs via coupled co-transcriptional pro-
cesses of trans-splicing and 30-end cleavage/polyadenyla-
tion (8). The process of trans-splicing involves the addition
of  40-bases long capped mini-exon to the 50-termini of
all mRNAs from a separate RNA substrate (SL-RNA)
[reviewed in (8)]. Transcription has been postulated to
initiate at strand switch regions on each chromosome
probably within the intercistronic regions (9,10). There
is, however, no indication for speciﬁc RNA polymerase
II promoters associated with protein-coding genes
to-date and the genomes of the parasites are short
of genes encoding major transcription factors and
co-activators. Consequently, most of gene regulation in
these parasites occurs at the post-transcriptional levels,
mainly via mRNA stability and translation [reviewed
in (11,12)].
Eukaryotic mRNAs are typically capped at their 50-ends
and possess poly(A) tail at their 30-ends. Such modiﬁca-
tions at the mRNA termini, plus the proteins they bind to,
confer mRNA stability and translatability. The degrada-
tion of eukaryotic mRNA is typically triggered by poly(A)
tail shortening [reviewed in (13)]. Deadenylation, in
turn, invokes decapping and the cumulative outcome
is unprotected ends that are readily attacked by 50- and
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have been identiﬁed in yeast, the nuclear Rat1p/Xrn2p
and the cytoplasmic Xrn1p (15,16). More than 10
conserved 30-exonucleases have been characterized and
some, together with other protein factors, are found in
a complex called the exosome. Besides their role in
determining mRNA half-lives in the cytoplasm, the
30- and 50-exonucleases are also involved in pre-mRNA
quality control and the maturation of ribosomal, nuclear
and small nucleolar RNAs [for examples see (17–19)]. In
yeast, degradation from the 50-end seems to be the major
determinant of mRNA degradation and the 30-pathway is
only detectable in mutants of the 50-pathway [reviewed in
(13)]. In mammals, there is a growing consensus that both
pathways are probably signiﬁcant determinants of mRNA
degradation (20–22).
The genomes of trypanosomes harbor genes that encode
for deadenylases [reviewed in (11)]. A clear orthologue of
a decapping enzyme has so far proven to be elusive even
though decapping activity has been detected in the related
organism Leptomonas seymouri (23). Degradation of
mRNAs in T. brucei involves both 50- and 30-pathways
(24) and homologues of all major 30-exonucleases (25–27),
and 50-exonucleases (28) are well-characterized. Trypano-
some 30-exonucleases are also found in a complex and
display all major RNA processing and degradation
functions associated with their counterparts in other
eukaryotes (25,26,29,30). Trypanosomes harbor four
homologues of Xrn1p and Xrn2p/Rat1p (28). One of
these, termed XRNA, is cytoplasmic and has been shown
to be critical in the degradation of both stable and
unstable mRNAs in T. brucei (28).
mRNA degradation cis determinants are predominantly
found in the 30-untranslated regions (UTRs) in all three
species of trypanomatids. In Leishmania, in contrast to
other trypansomatids, several hundred of the 30UTR cis-
elements belong to two major classes of short interspersed
degenerate retroposons, SIDER1 and SIDER2 (31), and
several lines of evidence indicate that these elements
modulate post-transcriptional gene expression in this
parasite (31–33). These elements are thought to have
evolved speciﬁcally in the Leishmania lineage perhaps
under the selective pressure presented by the parasite0s
unique niches. Whether or not the mechanisms through
which these elements function are also unique remains
to be determined. The degradation of several unstable
mRNAs in T. brucei [reviewed in (11) and T. cruzi (34)] is
dependent on U-rich elements (UREs). These elements
seem to be structurally (35) and functionally (24,29,36–40)
similar to the mammalian AU-rich elements (AREs)
found in several proto-oncogene and inﬂammatory
cytokine mRNAs (41). These elements confer instability
in a number of mRNAs in procyclic trypanosomes,
developmental forms of the parasite that reside in the
mid-gut of the insect vector. In T. cruzi, protein factors
(UBPs) that bind these elements with high aﬃnity and
avidity have been identiﬁed (34,42,43). Homologues of
these RNA-binding proteins also exist in T. brucei even
though these proteins seem to have broad RNA-binding
speciﬁcity (44). No UREs have been reported in
Leishmania so far and virtually nothing is known about
mechanisms underlying mRNA degradation in these
parasites. In this study, we demonstrate URE-mediated
degradation of the stage-speciﬁc amastin mRNA in
Leishmania, thereby embark on attempts to gain insight
into the mechanistic basis of mRNA degradation in this
organism.
MATERIALS AND METHODS
Plasmids
The parental plasmid used in this study, pSPBT1-
YNEOaLUC, was previously described (33). This plasmid
allows the integration of reporter constructs into the
BT1 genomic locus. Sequence corresponding to the
amastin (LinJ34_V3.1030) 30UTR and downstream
intergenic region was ampliﬁed by PCR from L. infantum
LEM 1317 genomic DNA (gDNA) using the forward
primer, amastin-30UTR-F (50-AAGCTACTTCGGA
TCCGCGG-30) and the reverse primer, amastin-IR-R
(50-GGATCCGGCTCGCCAGTGTAGCAGAA-30). The
URE deletion construct was made by fusion PCR as
described (45). Primers amastin-30UTR-F and amastin-
Up-URE-R (50-CGTCCATGCGGCTCTTCTCTGCGC
GTGCGTGTGTGTCG-30) were used to amplify the
upstream region from the URE. Primers amastin-Down-
URE-F (50-CGACACACACGCACGCGCAGAGAAGA
GCCGCATGGACG-30) and amastin-IR-R, was used to
amplify the downstream region of the URE. Primer
amastin-Up-URE-R is the reverse complement of primer
amastin-Down-URE-F. One hundred nanograms of the
resulting PCR products, together with primers Amastin-
30UTR-F and amastin-IR-R, were used for a fusion PCR
to generate amastin 30UTRiURE. The only diﬀerence
between full-length 30UTR and 30UTR-URE is, there-
fore, the deletion of the 100-nt long URE. The resulting
PCR fragments were digested with BamHI (primers
amastin-30UTR-F and amastin-IR-R contain this site)
and cloned into the BamHI site of the pSPBT1-
YNEOaLUC plasmid, downstream of the ﬁreﬂy luciferase
(LUC) open reading frame (Figure 2).
Parasite culture andtransfections
Leishmania donovani infantum MHOM/MA/67/ITMAP-
263, the parental strain for all the parasite lines employed
in this study, was cultured in SDM-79 medium (pH 7),
supplemented with 10% heat-inactivated fetal calf serum
(Multicell, Wisent Inc.) and 5mg/ml hemin at 258Ca s
promastigotes and were switched to MAA/20 medium
(pH 5.8) at 378C with 5% CO2 and passed  2–3 times to
generate axenic amastigotes (46). For genomic integration
into the BT1 locus,  2.5mgo fHpaI-HindIII digests (these
enzymes only cut on either side of the BT1 targeting
regions) were transfected into promastigote L. infantum by
electroporation as described (47). Transfected cells
were plated on SDM-79 medium with 1.5% agar and
0.01mg/ml of G418 (Sigma), and individual clones were
obtained after 2–3 weeks.
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Parasites were treated with 0.5mg/ml Actinomycin-D
(Sigma) with/without 2.5mM Sinefungin (Sigma) for
mRNA decay rate determination. All time points include
5min of centrifugation times. Total RNA was extracted
from cultures with OD600nm=0.3–0.5 after lysis with
Trizol (Invitrogen) according to the manufacturer’s
instructions. Ten to forty micrograms RNA was used
for standard RNA blotting. Hybridization was done at
428C with 50% formamide solution and RNA gels were
transfered into Hybond-N membranes (Amersham
Biosciences) by upward capillary movement. RNase-H
(Invitrogen) digestions were carried out as described with
20–60mg RNA as a starting material (48) in the presence
of a speciﬁc oligonucleotide 300R (50-TTGTCTCCGTT
CCTCC GGGATCCCG-30) with or without oligo dT
(Invitrogen) and the reaction contained RNase inhibitor
(Invitrogen). RNase H samples were run typically on
25cm 20cm, 2–2.4% agarose gels. Polyacrylamide gels
were 5% and transfer was carried out using BioRad’s
submarine system. Blots were probed with a fragment
corresponding the last 300 bases of the amastin mRNA.
Ten to twenty micrograms RNA was used as a starting
material for the Terminator (Epicentre Biotechnologies)
treatments of RNA samples. The reactions were carried
out according to manufacturer’s instructions at 308C for
1–1.5h and an RNase inhibitor (Invitrogen) was included
in the reaction. Minus Terminator controls were treated
equally except that the enzyme was not added. The
reaction was stopped by adding 5mM EDTA, and was
directly analyzed by an RNA blot after denaturation in
standard MOPS loading buﬀer. All quantiﬁcations of
RNA blots were done using the ImageQuant 5.2 software.
Luciferase assay
10
7 parasites were resuspended in 100ml of lysis buﬀer
(25mM Tris–phosphate at pH 7.8, 2mM dithiothreitol,
1% Triton X-100, 10% glycerol) and incubated at room
temperature for 30min, then transferred at  808C for 2h
or overnight. After thawing, 20ml of the parasite lysates
was added to 96-well plates. One hundred microliters
of luciferase assay buﬀer [20mM tricine, 1.07mM
(MgCO3)4.Mg(OH)2.5 H2O, 2.67mM MgSO4, 0.1mM
EDTA, 270mM coenzyme A, 470mM luciferin, 530mM
adenosine triphosphate, 33.3mM DTT] was added to each
well. Bioluminescence was measured using a Dynex MLX
luminometer.
RESULTS
Quantitative analysis ofthe stage-specific mRNA
regulationof the amastin mRNA
This study attempted to begin to elucidate mechanisms
underlying mRNA degradation in Leishmania using the
amastin mRNA as a model. The amastin gene encodes a
putative surface antigen and is a member of a multi-gene
family (49,50). What we refer to as amastin in this paper is
the original gene that was ﬁrst identiﬁed-LinJ34_v3.1030
(51). We previously demonstrated that most of the
amastin mRNAs accumulate preferentially in amastigotes
due to increased mRNA stability (49,51).
We ﬁrst wished to obtain a quantitative data on the
amastin mRNA regulation by using an additional probe
that is speciﬁc to the mRNA’s 30UTR, the last 300 bases
(probe 300) to exclude possible cross-reactivity with other
amastins. Overall the amastin mRNA is  3.9 more
abundant in axenic amastigotes than in promastigotes-
the developmental forms of the parasite that reside in the
mammalian host and the insect vector, respectively
(Figure 1A). The values obtained using the amastin
coding sequence as a probe and the probe 300 are
comparable and Figure 1A is representative of both. The
decay kinetics of mRNAs was followed upon inhibition of
Figure 1. Endogenous amastin mRNA steady-state levels and decay
kinetics. (A) RNA blot analysis of the amastin mRNA levels in
promastigotes (Pro) and amastigotes (Ama). 18S was used as a loading
control. Graphic representation of the data is shown in the right panel
and values are relative to promastigotes. Blots were probed with one
fragment which is complementary speciﬁcally to the last 300 bases of
the amastin 30UTR (probe 300, an average of three experiments), and
another probe corresponding to the amastin-coding region (ﬁve
experiments). (B) Decay kinetics of the amastin mRNA in promasti-
gotes and amastigotes. 18S was used as a loading control. Blots were
hybridized with probe 300. Note that the promastigote blot is over-
exposed and comparison of steady-state levels with the amastigote blot
is not advisable in this case. mRNA levels from diﬀerent time points
after transcriptional arrest with actinomycin-D (ACT-D) and inhibition
of splicing with Sinefungin (SIN) were expressed relative to time 0 and
data are representative of two experiments. ‘–15’ denotes pre-treatment
with SIN (including centrifugation time) before ACT-D is added at
time 0. Graphic representations of the experiments are shown in the
bottom panel. The absolute mRNA half-life values (t1/2) in promasti-
gotes and amastigotes are indicated. For mRNA half-life values derived
from ACT-D treatment alone see Table 1.
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cases together with the arrest of splicing using Sinefungin.
Sinefungin is assumed to prevent the splicing of pre-made
pre-mRNAs by inhibiting the de novo methylation of the
cap structure of the Spliced-Leader RNA (SL-RNA) and/
or mRNA maturation from incomplete transcriptional
inhibition. The combination of the two drugs was
previously suggested to be important in drawing a more
accurate representation of decay rates (11,30). Based on
an analysis using the probe 300, the amastin mRNA
decays with an overall half-life of  40min in promasti-
gotes versus >120min in amastigotes (Table 1, Figure 1B).
Stage-specific mRNA accumulation of theamastin mRNA
is mediated throughits 3’UTR
We asked if the stage-speciﬁc accumulation of the amastin
mRNA is mediated through sequences in the 30UTR, as is
the case for most trypanosomatid mRNAs studied to date.
For this and subsequent analysis, we made a bicistronic
Neomycin-Luciferase (NEO-LUC) construct which con-
tained the 30UTR and the downstream intergenic region of
the endogenous amastin locus directly after the LUC-
coding sequence (Figure 2A). The construct also included
additional intergenic and artiﬁcial sequences that allowed
the proper maturation of the reporter LUC and the
selectable marker NEO mRNAs. The NEO-LUC cassette
is ﬂanked by sequences that allowed the targeting of the
construct into the Biopterin Transporter 1 (BT1) genomic
locus by homologous recombination (data not shown).
The protein encoded by the BT1 gene is not required
under culture conditions in biopterin-rich media but it is
essential otherwise (52). The BT1 locus is, therefore, used
routinely for the integration of transgenic constructs,
particularly when a physiologically relevant expression
level is desirable. All the other sequences except the
30UTR have been used routinely in several published [e.g.
(33)] and unpublished reporter gene analysis and they
do not aﬀect RNA levels between promastigotes and
amastigotes. Any diﬀerence in the LUC-amastin 30UTR
mRNA (LUC-30UTR) levels should therefore be due to
the amastin 30UTR. Figure 2B shows that LUC-30UTR
mRNA is  3.2-fold higher in amastigotes than in
promastigotes, comparable with the regulation of the
endogenous amastin mRNA (Figure 1A). mRNA decay
analysis of the LUC-30UTR showed that its half life is
 30min in promastigotes and  80min in amastigotes
(Table 1, Figure 3). In promastigotes,  50–60% the LUC-
30UTR mRNA population are degraded with a half-life of
 10–15min (Figure 3A and B). The rest of the population
(40–50%) is degraded with a slower kinetics, the half-life
being  45min (Figure 3A and B, data not shown). These
results suggest that the stage speciﬁcity of the steady-state
levels and degradation kinetics of the amastin mRNA are
mediated mainly through sequences in its 30UTR and that
degradation is probably bi-phasic.
AU-rich»100basesregioninthe3’UTRoftheamastinmRNA
contributes significantly toits stage-specific accumulation
andits facilitated degradation in promastigotes
Next, we assessed whether the amastin mRNA regulation
could be attributed to a distinct element in its 1.8kb long
30UTR. We have previously shown that the last 770 bases
region of the amastin 30UTR, in-and-by itself, does not
account for stage-speciﬁc accumulation of the amastin
mRNA (33). Sequence scanning of the rest of the 30UTR
revealed that it contains a  100 bases long U-rich
sequence (URE) (Figure 2A). Given the role of similar
elements in the degradation of unstable mRNAs in other
eukaryotes including T. brucei and T. cruzi [reviewed in
(11,34)], we deleted this region in a construct which is
otherwise identical to the LUC-30UTR plasmid. The
stable transfectant of this plasmid (LUC-30UTRURE)
was analyzed in parallel with that of the LUC-30UTR.
Copy number diﬀerences were ruled out by Southern blot
analysis and comparison of NEO mRNA levels (data not
shown). As shown in Figure 2B, the LUC-30UTRDURE
mRNA steady-state levels are  2.2-fold higher than that
of LUC-30UTR in promastigotes whereas no signiﬁcant
diﬀerence could be observed in amastigotes, suggesting
that the URE accounts signiﬁcantly for the stage-speciﬁc
accumulation of the amastin mRNA. Decay analysis
showed that the diﬀerence in the steady-state levels
between LUC-30UTR and LUC-30UTRDURE mRNA
levels observed in promastigotes is accompanied by an
overall increase in mRNA half-life from  30 to >60min
(Figure 3A and B, Table 1). No signiﬁcant changes could
be detected in amastigotes (Figure 3C, Table 1). A more
detailed comparison revealed that diﬀerences in degrada-
tion kinetics are more apparent in the initial phase
(the ﬁrst 15–30min) than the later phase (Figure 3A
and B). Luciferase activity levels generally followed the
mRNA trends (Figure 2C, data not shown) and the URE-
mediated mRNA degradation is, therefore, unlikely to be
to due to diﬀerential translatability of the mRNA. Taken
together, these results suggested that a signiﬁcant part
of the amastin mRNA degradation in promastigotes is
Table 1. mRNA half-lives for the endogenous amastin and reporter
mRNAs analysed in this study
mRNA mRNA half-lives (min)
ACT-D ACT-D+SIN
Pro Ama Pro Ama
Amastin 45 20 >120 45 15 >180
LUC-30UTR 31.3 19.6 82.5 10.6 28 15.5
a 115 10
LUC-30UTRURE >120 76 1.4 63 21.3
a 137 5
Decay rates for the endogenous amastin, LUC-30UTR and LUC-
30UTRDURE mRNAs in promastigotes (Pro) and axenic amastigotes
(Ama) were determined after transcriptional inhibition using
Actinomycin D (ACT-D) with or without splicing arrest using
Sinefungin (SIN).
aDespite the variation of the absolute half-life values which are directly
reﬂected in this Table, LUC-30UTRDURE mRNA was consistently
more stable than LUC-30UTR mRNA in promastigotes in each of the
four independent experiments we carried out whereas no signiﬁcant
diﬀerences were observed between these two RNAs in amastigotes.
Numerically, this parameter is reﬂected by the average of the relative
diﬀerences (the half-life of LUC-30UTRDURE mRNA minus that of the
LUC-30UTR mRNA), which is 34min an SD of 8min.
Nucleic Acids Research, 2008, Vol. 36, No. 5 1637URE-mediated and that this probably occurs during the
initiation phase of the degradation.
Differential degradation of theamastin mRNA
inpromastigotes seems tobe initiated via
deadenylation-independent mechanisms
mRNA degradation in eukaryotes is typically initiated
and modulated via diﬀerential deadenylation [reviewed in
(13)]. Thus, we asked if the promastigote-speciﬁc degrada-
tion of the amastin mRNA is due to rapid deadenylation.
The endogenous amastin or LUC-30UTR mRNAs are
relatively long ( 2.6 and  3.5kb, respectively) and
changes in mRNA sizes due to deadenylation in ordinary
RNA blot analysis would be diﬃcult to visualize. We,
therefore, like in many other previous studies by others
[e.g. (24)], exploited the DNA–RNA hybrid-dependent
ribonuclease activity of RNase H to cleave these RNAs
at speciﬁc sites and generate shorter 30-end fragments.
This was achieved by incubating RNA samples from
several time points after ACT-D   SIN treatments with
RNase H in the presence of anti-sense oligonucleotide
targeted to a region of  300 bases from the end of the
amastin 30UTR (Figure 4A). Oligo dT was added in some
samples so that the poly(A) tail could be cleaved oﬀ and
the resulting fragment served as a marker for a  100%
deadenylated mRNA species. This analysis in promasti-
gotes showed that the poly(A) tail of the LUC-30UTR
mRNA is still intact (relative to time 0) long after a
signiﬁcant part of the mRNA body has been degraded
(Figure 4B, left panel). In contrast, a signiﬁcant dead-
enylation clearly precedes the degradation of the mRNA
in amastigotes (Figure 4B, right panel). Interestingly, the
deadenylation pattern of the relatively more stable LUC-
30UTRDURE mRNA was not diﬀerent between promas-
tigotes (Figure 4B, middle panel) and amastigotes (data
not shown) and it remarkably resembles that of LUC-
30UTR in amastigotes (Figure 4B, right panel).
Noteworthy, a minor population of the LUC-30UTR
mRNA in promastigotes appears to be deadenylated at
Figure 2. The use of reporter mRNAs to demonstrate the role of speciﬁc 30UTR sequences in the stage-speciﬁc accumulation of the amastin mRNA.
(A) Schematic representation of the reporter constructs, LUC-30UTR and LUC-30UTRURE. The exact sequence of the U-rich element (URE) that
is deleted in LUC-30UTRURE is indicated. The NEO-LUC bicistron is ﬂanked with sequences that allow construct targeting to the endogenous
BT1 locus via homologous recombination. Y is a polypyrimidine stretch that allows 50-end splicing of the Neomycin phosphotransferase (NEO)
mRNA. aTub IR stands for the intergenic region of the alpha-tubulin gene and allows the 30-end maturation of the NEO mRNA and the
50-maturation of the Luciferase (LUC) mRNA. Ama IR denotes the intergenic region of the amastin gene, which allows the 30-end maturation of the
LUC mRNA. (B) RNA blot analysis of LUC-30UTR and LUC-30UTRDURE mRNA levels in promastigotes (Pro) and amastigotes (Ama). 18S was
used as a loading control. Graphic representation of the steady-state reporter mRNA levels is indicated in the right panel. Values are expressed
relative to promastigote LUC-30UTR mRNA levels. Data are derived from two to three experiments but 11 experiments for the LUC-30UTR versus
LUC-30UTRDURE comparisons in promastigotes. The P-value for the LUC-30UTR versus LUC-30UTRDURE in promastigotes is shown and was
calculated using Excel’s Type 3 two-tailed T-test. (C) Luciferase activity in promastigotes. Luciferase (LUC) protein levels were inferred by measuring
LUC enzymatic activity. Data are derived from three experiments.
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4C) and is probably coincident with the second and slower
phase of the mRNA degradation (Figure 3A and B).
We carried out a similar analysis for the endogenous
amastin mRNA both in promastigotes and amastigotes.
In order to detect the deadenylation pattern of the
endogenous amastin mRNA in promastigotes (expression
of the amastin mRNA is much higher in amastigotes
compared to promastigotes), we had to increase the
sensitivity of the assay and to expose the Northern blots
much longer. This analysis shows that consistent with the
reporter mRNA results described earlier (Figure 4B, left
panel), the amastin mRNA in promastigotes—in contrast
to the same mRNA in amastigotes—is degraded without
detectable deadenylation (Figure 5A and C upper panel).
We next wanted to assess the deadenylation proﬁle of the
amastin mRNA during diﬀerentiation. To induce diﬀer-
entiation in vitro, we subject amastigotes grown at 378C
and pH 5.8 to promastigote conditions (258C and pH 7.0)
of growth. Approximately 5h following the switch from
amastigote to promastigote conditions, a signiﬁcant
decrease in amastin mRNA levels could be observed
(Figure 5B). Interestingly, under these conditions, the
deadenylation pattern of the endogenous amastin mRNA
(Figure 5C lower panel) was comparable to that seen using
adapted promastigote cultures (Figure 5A). Overall, these
results suggest that the initial phase of the degradation of
the amastin mRNA in promastigotes per se is likely to be
deadenylation-independent and that the stage-speciﬁc
regulation of the amastin mRNA is unlikely to be a
function of diﬀerential deadenylation rate.
Isdecapping therate-limiting step forthe
promastigote-specific degradation of theamastin mRNA?
Deadenylation-independent mechanisms of mRNA degra-
dation are rare in eukaryotes and are mainly initiated via
an endonuclease or deadenylation-independent decapping
activities. A role for a decapping mechanism is usually
demonstrated via genetic or RNA interference (RNAi)
approaches. However, no clear homologue of a decapping
Figure 3. Decay kinetics of reporter mRNAs. mRNA decay rate was followed after inhibition of transcription alone with Actinomycin D (ACT-D)
for LUC-3’UTR versus LUC-30UTRDURE in promastigotes (Pro) (A), ACT-D plus Sinefungin (SIN) for LUC-30UTR versus LUC-30UTRDURE in
Promastigotes (B) and ACT-D alone for LUC-30UTR versus LUC-30UTRDURE in amastigotes (Ama) (C). ‘–15’ time point in (B) represents a pre-
treatment with SIN (including centrifugation time) before the addition of ACT-D at time 0. Histone 4A (Hist4A) was used as a loading control.
Graphic representations of mRNA decay rates are indicated on the right panels where mRNA levels from diﬀerent time points (after ACT-D with or
without SIN treatments) were expressed relative to time 0. Data are derived from two experiments for the amastigote data and four experiments for
the promastigote data. The absolute mRNA half-life values (t1/2) are indicated. See Table 1 for the entire complement of mRNA half-lives calculated
in this study and their corresponding standard errors.
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trypanosomatids. We, therefore, resorted in this study into
an indirect assessment of the decapping rate of the LUC-
30UTR mRNA versus the LUC-30UTRDURE mRNA in
promastigotes. To do this, we took advantage of
the commercially available 50-phosphate-dependent
riboexonuclease, Terminator, which has so far been used
mainly to enrich mRNA preparation as the enzyme
degrades all uncapped RNAs (e.g. decapped mRNAs,
rRNAs, tRNAs) while capped mRNAs are protected.
A recent study has made use of the enzyme to qualitatively
access the cap status of a deadenylated intermediate of
the hsp70 mRNA (53). Here, we anticipated that relative
mRNA decapping rates could quantitatively be inferred
by comparison of Terminator treated versus untreated
RNA samples derived from various time points after
transcriptional arrest. For this assay, uncapped rRNAs
that are cleaved by the enzyme served as positive controls
(with 50–80% eﬃciency in our case). Histone 4A (Hist4A)
mRNA is very stable within the time points used in the
assay and therefore served as a negative control and
indicated that the enzyme is highly speciﬁc (Figure 6A).
Tube-to-tube variations in the eﬃciency of the Terminator
activity were corrected with the levels of 18S RNA after
loading normalization with the Hist4A mRNA
(Figure 6A). Values from Terminator-treated samples
were then divided by those from Terminator-untreated
samples. The resulting numbers for each of the various
time points after ACT-D treatment were expressed as a
function of time 0. Such analysis indicated that there is no
signiﬁcant diﬀerence between the percentage of capped
LUC-30UTR and LUC-30UTRDURE mRNAs at various
Figure 4. Determination of poly(A) tail status during reporter mRNA decay. (A) Schematic representation of the deadenylation assay. RNase-H
digests DNA/RNA hybrid. In this case the DNA is an oligonucleotide (300R), which is reverse complementary to a region of  300 bases upstream
of the poly(A) tail of the reporter mRNA. The presence of oligo dT in the reaction allows the trimming of the poly(A) tails (see later). The vertical
darker arrows indicate the sequence to which the oligonucleotide was targeted into. The last 300 bases of the 30UTR is underlined and is where the
probe for the RNA blots was targeted. (B) Deadenylation of reporter mRNAs in promastigotes (Pro) and amastigotes (Ama). RNA samples were
collected from diﬀerent time points after treatment with ACT-D and subjected to RNase-H treatment. 30 fragments were analysed by RNA blot. At
time 0, RNA samples were also treated with RNase-H digestion in the presence of oligo dT (in addition to the speciﬁc oligonucleotide) to generate
poly(A) minus 30-end markers (‘0 + dT’ lanes). Hist 4A is used as a loading control. (C) As in (B) but RNA was derived from ACT-D and SIN
treatment of LUC-30UTR promastigotes. Data are representative of three experiments. (D) Quantitative representation of the decay rate of LUC-
30UTR polyadenylated 30-end fragments in promastigotes (B, left panel) is compared to that of the full-length LUC-30UTR mRNA in promastigotes
(Figure 3A). The lateral bracket indicated in Figure 4B left panel shows the portion of the gel used for quantiﬁcation of the largely poly(A)+ 30-end
fragments. Note that the full-length LUC-30UTR mRNA used for this quantiﬁcation was probed by the luciferase coding sequence, which is  1.8kb
upstream of the polyadenylation site while the 30-end products of the RNase H were probed by the last 300 terminal sequence of the 30-end.
1640 Nucleic Acids Research, 2008, Vol. 36, No. 5time points after transcriptional arrest (relative to time 0)
(Figure 6B). These results, within the limits of the assay
employed, suggested that no detectable diﬀerence in
decapping rate can account for the URE-mediated
facilitated degradation of the amastin mRNA in
promastigotes.
DISCUSSION
In this study, we began a series of experiments aimed at
dissecting the mechanisms of mRNA degradation respon-
sible for the expression of stage-speciﬁc mRNAs in
Leishmania. Speciﬁcally, we studied the degradation of
the amastin mRNA, which was previously shown to be
more abundant in amastigotes than in promastigotes (51).
Further interest in undertaking this study stems from the
observations that the amastin gene encodes a putative
surface protein and is a member of multi-gene family with
an expected role in the biology and/or pathobiology of the
parasite (49,50).
In common with a number of other previously studied
mRNAs, the stage-speciﬁc amastin mRNA is regulated
via sequences in its 30UTR at the level of mRNA stability.
Sequence analysis of its 30UTR revealed the presence of a
 100 bases long U-rich sequence (URE) and our reporter
mRNA analysis showed that this element contributes
signiﬁcantly to the stage-speciﬁc accumulation and degra-
dation of the amastin mRNA. A similar role of UREs was
previously shown for T. brucei and T. cruzi mRNAs
[reviewed in (11,34)], suggesting that this mechanism is
probably conserved in trypanosomatids. Noteworthy, the
designation of this element as a URE, and its reference
relative to elements in other eukaryotes, is solely based on
the relatively high (50%) U-content of the region. Also,
the speciﬁc regulatory region within the element, if distinct
at all, might not necessarily be as U-rich.
The URE does not seem to account for all of the stage-
speciﬁc regulation of the amastin mRNA. If any, the rest
of the amastin mRNA regulation might be explained
by other elements in its 1.8kb 30UTR. The 30UTR of
the amastin mRNA contains a sequence related to the
Figure 5. Deadenylation analysis of the endogenous amastin mRNA.
(A) RNase H-RNA blot deadenylation assay for assessing dead-
enylation of the endogenous amastin mRNA in promastigotes. RNA
samples were collected at 0, 15 and 30min (half-life of the endogenous
mRNA in promastigotes, see Figure 1B) following transcriptional arrest
with Actinomycin-D (ACT-D) (left panel) and treatment with ACT-D
plus Sinefungin (SIN) to inhibit splicing (right panel) and subjected to
RNase-H treatment as detailed in Figure 4 and under ‘Materials and
Methods’ section. (B) Time-point analysis of the amastin mRNA
during a switch from axenic amastigote (Ama) (pH 5.8, 378C) to
promastigote (Pro) (pH 7.0, 258C) conditions. Blots were probed with
the probe 300 fragment. (C) RNase H-RNA blot deadenylation assay.
The 5h post-switch was selected based on the data presented in (B),
a time point where a detectable decrease in mRNA level was observed
and yet not down to an extent below the detection limit of the
deadenylation assay. RNA samples were run on 5% polyacrylamide
gels. Other methodological details for the deadenylation analysis are as
in Figure 4. The data are representative of two experiments.
Figure 6. Indirect measurement of decapping rates. (A) RNA samples
were derived from LUC-30UTR and LUC-30UTRURE lines treated
with actinomycin-D (ACT-D) for diﬀerent time points. An equal
volume of RNA was separated into two diﬀerent tubes. One set of the
tubes contained the reaction mix containing the Terminator enzyme
(+ lanes) and the other contained the same mix but without the
enzyme (– lanes). Both Terminator – and + reactions were incubated
for 1–1.5h according to manufacturer’s instructions (Epicentre
Biotechnologies). Data are representative of two experiments. Similar
results were obtained in two other experiments involving ACT-D and
SIN (data not shown). 18S RNA signals were used to control for tube-
to-tube variation of Terminator degradation eﬃciency after normal-
ization of loading with histone 4A (Hist4A) mRNA. (B) Graphic
representation of the ratio of + Terminator signals to – Terminator
signals relative to time 0.
Nucleic Acids Research, 2008, Vol. 36, No. 5 1641Leishmania speciﬁc SIDER1 retroelements (31). We have
previously shown that the amastin SIDER1 alone
does not alter reporter RNA levels (33). However, the
possibility that it might have a context dependent
function, perhaps in synergy with the URE, remains to
be tested.
mRNA decay analysis of the amastin mRNA revealed a
remarkable resemblance of degradation kinetics with that
of unstable mRNAs in T. brucei. Unlike the degradation
of the stable mRNAs, at least the initial phase of the
degradation of unstable URE-containing mRNAs appears
to be deadenylation-independent (24,29). At least at ﬁrst
glance, an alternative interpretation of the deadenylation
analysis we employed in this study can be associated with
the possibility that deadenylated species of the endogen-
ous amastin or LUC-30UTR mRNAs in promastigotes
might be degraded too fast to be detectable. Our data do
not rule out the singular possibility that deadenylated
amastin mRNA species might be degraded faster in
promastigotes. However, whether the diﬀerential degrada-
tion of the amastin mRNA is mediated through and/or
preceded by undetectable deadenylation is altogether a
diﬀerent question. Several indications seem to go against
this possibility. First, there are no appreciable levels of
deadenylated species at time 0 and at early time points
following actinomycin D treatment. Secondly, deadeny-
lated species are actually detectable in the later time points
(Figure 4B left panel and Figure 4C). Thirdly, as mRNAs
get deadenylated, there must be a proportional decrease of
the poly(A) plus mRNAs. This would imply that the
remaining polyadenylated portion of the 30-end fragments
should disappear faster relative to the full-length mRNA.
However, our results did not indicate that this is the case
(Figures 3 and 4). In fact, the decay kinetics of the non-
deadenylated 30-end fragments was not distinguishable
from those of the full-length, RNase-H-untreated mRNAs
(Figure 4D). Fourthly, we did not observe detectable
diﬀerences when we compared degradation from the
50- and 30-ends in RNase H-RNA blots using an
oligonucleotide that allowed cutting at  800 bases
upstream of the 30-end and subsequent detection with
region-speciﬁc probes (see Supplementary Data in
Figure S1). Indeed, RNAi-mediated depletion of a
homologue of a yeast deadenylase in T. brucei has
minimal eﬀects on the degradation kinetics of unstable
mRNAs (including URE-mRNAs) while that of moder-
ately and highly stable mRNAs is clearly altered (personal
communication by Dr Clayton, ZMBH, Germany). These
observations collectively compelled us to conclude that the
URE-mediated promastigote-speciﬁc degradation of the
amastin mRNA is deadenylation-independent. It is,
therefore, tempting to suggest that the likely possibility
that deadenylated species might be degraded faster in
promastigotes can instead be viewed as further evidence to
our conclusion; namely that URE amastin mRNAs are
degraded faster in promastigotes regardless of whether
they contain poly(A) or not (i.e. degradation is indepen-
dent of deadenylation status).
Signiﬁcant levels of deadenylated species are detectable
at steady-state in both stages of the parasite. This is a
surprising observation because deadenylated mRNAs are
considered to be unstable. Interestingly, a recent global
analysis of poly(A) length of mammalian mRNAs has
revealed a surprisingly high proportion of the mRNAs
( 25%) having oligoadenylated species with only <30
length of poly(A) (54). Even a more surprising ﬁnding of
the study by Meijer et al. is that some stable mRNAs fall
among these mRNAs. For example, 25% of the beta-actin
mRNA, an mRNA known to be very stable, contained a
short poly(A) tail. These observations collectively chal-
lenge the current notion that deadenylated mRNA species
are unstable. A related observation in this study is that a
higher proportion of deadenylated and oligoadenylated
species are detected for stable mRNAs (the amastin
or LUC-30UTR mRNAs in amastigotes and the LUC-
30UTRDURE mRNA in both stages) than unstable
mRNAs (the amastin and LUC-30UTR mRNAs in
promastigotes). This can be because the deadenylated
species are degraded faster in promastigotes.
Alternatively, this can be viewed as an indication for the
possibility that the URE-mediated regulation of the
amastin mRNA is not only deadenylation-independent
but also polyadenylation-dependent. In other words,
the poly(A) tail might have a destabilizing role rather
than a stabilizing one. In bacteria, poly(A) tail serves as
a ‘holding toe’ for 30-exonucleases thereby facilitating
degradation (55). However, this is not the case for almost
all functional eukaryotic mRNAs studied so far. The
few cases where poly(A) tail has a destabilizing function
in eukaryotes fall within the realms of nuclear RNA
degradation of certain pre-mRNAs and/or aberrant
mRNAs as part of quality-control mechanisms (56–58).
Mechanisms of deadenylation-independent mRNA
degradation, albeit rare, include deadenylation-indepen-
dent decapping mechanisms such as the one associated
with at least one pathway of the non-sense-mediated decay
(59,60). Unfortunately, no clear homologue to any of the
decapping enzymes from other eukaryotes has so far been
identiﬁed in the genomes of trypanosomatids even though
in vitro decapping activity was biochemically detected
in a related species (23). In this study, we attempted to
indirectly compare decapping rates by taking advantage
of a 50-phosphate-dependent enzyme, Terminator. This
analysis did not show a signiﬁcant diﬀerence between
LUC-30UTR and LUC-30UTRDURE mRNAs in promas-
tigotes suggesting the diﬀerential mRNA degradation
is unlikely to be a function of an altered decapping rate.
We, therefore, favor the scenario that an endonuclease-
mediated cleavage might be the rate-limiting step, a
well-studied example of which can be found in the
degradation of the mammalian alpha-globin mRNA
[reviewed in (61)]. Alternatively, a novel pathway might
be awaiting a discovery.
Our current model of the amastin mRNA degradation
based on this study, and in analogy with the situation in
T. brucei, is that two mechanisms are likely to be involved:
one that appears to be deadenylation- and decapping-
independent, URE-mediated rapid degradation that is
developmentally regulated, and the other is constitutive,
which is likely to be slower and deadenylation-dependent
(Figure 7). This study is the ﬁrst not only in reporting
a URE-mediated degradation in Leishmania but also in
1642 Nucleic Acids Research, 2008, Vol. 36, No. 5attempting to draw the mechanistic basis of diﬀerential
mRNA degradation in this parasite. The extent to which
URE-mediated degradation diﬀers from mammalian
ARE-mediated mRNA instability and whether there are
species-speciﬁc aspects of this mechanism among trypa-
nosomatids remain to be determined.
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